Literature DB >> 35618851

Effect of topical and intraventricular antibiotics used during ventriculoperitoneal shunt insertion on the rate of shunt infection-a meta-analysis.

Ganesh Vl1, Kanwaljeet Garg2, Vivek Tandon1, Sachin A Borkar1, G D Satyarthi1, Manmohan Singh1, P S Chandra1, S S Kale1.   

Abstract

INTRODUCTION: The ventriculoperitoneal shunt is one of the most commonly performed neurosurgical procedures. One of the avoidable complications of shunt surgery is shunt infection. This PRISMA-compliant meta-analysis analysed the effectiveness of topical and/or intraventricular antibiotics in preventing shunt infections in patients undergoing shunt surgery.
METHODS: Four databases were searched from inception to 30th June 2021. Only original articles comparing the rate of shunt infection with and without antibiotics were included. Random-effects meta-analysis was used to compare the effect of the use of antibiotics in preventing infection and subgroup analysis for finding differences in various antibiotics.
RESULTS: The rate of shunt infection was 2.24% (53 out of 2362) in the topical antibiotic group in comparison to 5.24% (145 out of 2764) in the control group (p = 0.008). Subgroup analysis revealed that there is no significant difference between the antibiotics used.
CONCLUSIONS: Our meta-analysis found that the risk of shunt infection is significantly reduced with the use of topical and intraventricular antibiotics without any serious adverse effect. No side effects of topical or intraventricular antibiotics were reported in the included studies. Further prospective studies are required to establish the safety and optimal dosage of topical antibiotics for them to be used routinely in neurosurgical practice. They can be used in patients at high risk of developing shunt infections till such studies are available.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Austria, part of Springer Nature.

Entities:  

Keywords:  Antibiotics; Intraventricular; Shunt infection; Topical; VP shunt; Ventriculoperitoneal shunt

Mesh:

Substances:

Year:  2022        PMID: 35618851     DOI: 10.1007/s00701-022-05248-0

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.816


  3 in total

1.  Ventriculoperitoneal shunt infection rates using a standard surgical technique, including topical and intraventricular vancomycin: the Children's Hospital Oakland experience.

Authors:  Kunal P Raygor; Taemin Oh; Joan Y Hwang; Ryan R L Phelps; Kristen Ghoussaini; Patrick Wong; Rebecca Silvers; Lauren R Ostling; Peter P Sun
Journal:  J Neurosurg Pediatr       Date:  2020-07-24       Impact factor: 2.375

Review 2.  Efficacy of antimicrobial medicated ventricular catheters: a network meta-analysis with trial sequential analysis.

Authors:  Revanth Goda; Akshay Ganeshkumar; Varidh Katiyar; Ravi Sharma; Hitesh Kumar Gurjar; Aprajita Chaturvedi; Roshan Sahu; Hitesh Inder Singh Rai; Zainab Vora
Journal:  Neurosurg Rev       Date:  2021-05-19       Impact factor: 3.042

3.  Efficacy and safety of intrathecal meropenem and vancomycin in the treatment of postoperative intracranial infection in patients with severe traumatic brain injury.

Authors:  Qiang Zhang; Hongxing Chen; Chao Zhu; Fangzhou Chen; Suohui Sun; Nan Liang; Wei Zheng
Journal:  Exp Ther Med       Date:  2019-04-18       Impact factor: 2.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.